Sorry, this entry is only available in Ελληνικά.
European Commission Press Releases - 82. page
(Ελληνικά) Ιθαγένεια της ΕΕ: Νέα έρευνα δείχνει ότι οι πολίτες της ΕΕ είναι καλύτερα ενημερωμένοι για τα δικαιώματά τους
Sorry, this entry is only available in Ελληνικά.
24 new European Universities reinforce the European Education Area
European Universities are transnational alliances of higher education institutions from across the EU that come together for the benefit of students, teachers and society. Today, the European Commission has unveiled […]
(Ελληνικά) 24 νέα «ευρωπαϊκά πανεπιστήμια» ενισχύουν τον Ευρωπαϊκό Χώρο Εκπαίδευσης
Sorry, this entry is only available in Ελληνικά.
Powering a climate-neutral economy: Commission sets out plans for the energy system of the future and clean hydrogen
To become climate-neutral by 2050, Europe needs to transform its energy system, which accounts for 75% of the EU’s greenhouse gas emissions. The EU strategies for energy system integration and […]
Migration: Relocation of unaccompanied children from Greece to Portugal and Finland
On 7 and 8 July, 49 unaccompanied children were relocated from Greece to Portugal and Finland as part of a scheme organised by the Commission and the Greek Special Secretary […]
(Ελληνικά) Μετεγκατάσταση ασυνόδευτων παιδιών από την Ελλάδα στην Πορτογαλία και τη Φινλανδία
Sorry, this entry is only available in Ελληνικά.
Protecting European Consumers: follow-up action on dangerous product alerts increased significantly in 2019
Today, the European Commission published its latest report on the Commission’s system to prevent or restrict the selling of dangerous products on the market, the so-called ‘Rapid Alert System‘. The […]
(Ελληνικά) Προστασία των Ευρωπαίων καταναλωτών
Sorry, this entry is only available in Ελληνικά.
Coronavirus: Commission and EIB provide CureVac with a €75 million financing for vaccine development and expansion of manufacturing
The European Investment Bank (EIB) and CureVac, abiopharmaceutical company developing innovative medicines based on optimised messenger ribonucleic acid (mRNA), entered into a €75 million loan agreement to support the company’s […]
